Matrix-Bio

MatrixBio develops metabolite-profiling technology for disease diagnosis, drug therapy analysis, and drug development.

Breast cancer is the second most common cancer in American women, claiming more than 41,000 lives each year. Many women at high risk live with constant worry. Once a woman is diagnosed with breast cancer, it never leaves her side even if it is in remission. Providing an alternative to fear in the form of more accurate, reliable tests for the detection and monitoring of breast cancer is what drives Matrix-Bio to excel in the emerging field of metabolite profiling.